China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE: 300294)
China
· Delayed Price · Currency is CNY 33.68
+0.40 (1.20%)
Sep 9, 2024, 12:49 PM CST
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 227.52 | 237.47 | 432.2 | 344.53 | 260.06 | 426.15 | Upgrade
|
| Depreciation & Amortization | 90.59 | 95.71 | 97.03 | 99.35 | 81.34 | 82.77 | Upgrade
|
| Other Amortization | 19.59 | 18.26 | 13.74 | 13.63 | 13.26 | 11.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.98 | -1.3 | -0.07 | 0.87 | 1.58 | -1.44 | Upgrade
|
| Asset Writedown & Restructuring Costs | 326.25 | 326.72 | 53.65 | 80.57 | 0.27 | 0.19 | Upgrade
|
| Loss (Gain) From Sale of Investments | -79.37 | -99.75 | -43.84 | -43.11 | -10.14 | -0.13 | Upgrade
|
| Provision & Write-off of Bad Debts | 5.39 | 2.37 | 2.8 | 0.05 | -9.29 | 6.06 | Upgrade
|
| Other Operating Activities | 8 | 14.46 | 13.92 | 31.26 | 38.39 | 48.93 | Upgrade
|
| Change in Accounts Receivable | 477.13 | 40.02 | -11.73 | 799.83 | 390.43 | -647.64 | Upgrade
|
| Change in Inventory | 3.52 | 107.01 | 1.28 | 11.77 | -68.54 | -18.63 | Upgrade
|
| Change in Accounts Payable | -608.59 | -92.32 | 56.24 | 4.14 | 15.9 | -11.64 | Upgrade
|
| Change in Unearned Revenue | -3.57 | -3.57 | -4.13 | -1.46 | - | - | Upgrade
|
| Change in Other Net Operating Assets | - | - | 3.28 | 11.59 | - | - | Upgrade
|
| Operating Cash Flow | 460.2 | 641.73 | 596.44 | 1,345 | 718.58 | -114.51 | Upgrade
|
| Operating Cash Flow Growth | -39.52% | 7.59% | -55.67% | 87.23% | - | - | Upgrade
|
| Capital Expenditures | -83.98 | -87.5 | -138.41 | -68.12 | -142.51 | -88.61 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.11 | 3.26 | 0.33 | 4.41 | 1.66 | 3.77 | Upgrade
|
| Divestitures | 378.43 | 269 | - | - | - | - | Upgrade
|
| Investment in Securities | 707.89 | -248.85 | -500 | -2,505 | 7.02 | -188.39 | Upgrade
|
| Other Investing Activities | 87.78 | 78.33 | 77.86 | 32.4 | 5.5 | 0.13 | Upgrade
|
| Investing Cash Flow | 1,094 | 14.25 | -560.22 | -2,536 | -128.34 | -273.1 | Upgrade
|
| Long-Term Debt Issued | - | 22.15 | - | 251.85 | 820 | 1,261 | Upgrade
|
| Long-Term Debt Repaid | - | -24.98 | -3.82 | -563.55 | -1,113 | -1,245 | Upgrade
|
| Net Debt Issued (Repaid) | -2.77 | -2.83 | -3.82 | -311.7 | -292.56 | 16.06 | Upgrade
|
| Issuance of Common Stock | - | - | - | 2,400 | - | - | Upgrade
|
| Common Dividends Paid | -185.33 | -134.9 | -83.19 | -46.03 | -88.81 | -94.58 | Upgrade
|
| Other Financing Activities | -59.62 | -98.91 | 2 | -9.64 | -9.09 | -159.07 | Upgrade
|
| Financing Cash Flow | -247.72 | -236.65 | -85.01 | 2,032 | -390.46 | -237.59 | Upgrade
|
| Net Cash Flow | 1,307 | 419.33 | -48.79 | 841.39 | 199.78 | -625.21 | Upgrade
|
| Free Cash Flow | 376.22 | 554.23 | 458.03 | 1,277 | 576.07 | -203.13 | Upgrade
|
| Free Cash Flow Growth | -36.47% | 21.00% | -64.14% | 121.72% | - | - | Upgrade
|
| Free Cash Flow Margin | 18.75% | 20.90% | 16.60% | 48.19% | 22.92% | -6.98% | Upgrade
|
| Free Cash Flow Per Share | 0.74 | 1.10 | 0.91 | 2.93 | 1.35 | -0.48 | Upgrade
|
| Cash Income Tax Paid | 188.99 | 250.39 | 227.94 | 192.85 | 190.04 | 265.88 | Upgrade
|
| Levered Free Cash Flow | 253.13 | 379.32 | 354.85 | 1,141 | 449.92 | -366.38 | Upgrade
|
| Unlevered Free Cash Flow | 253.3 | 379.6 | 355.24 | 1,148 | 463.33 | -347.16 | Upgrade
|
| Change in Net Working Capital | 88.43 | -19.35 | -65.91 | -843.82 | -304.88 | 679.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.